{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:08:33Z","timestamp":1788923313885,"version":"build-2803163510"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AL210095"],"award-info":[{"award-number":["AL210095"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Research Council Centre of Excellence in Quantum Biotechnology","award":["CE230100021"],"award-info":[{"award-number":["CE230100021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03764-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:16:50Z","timestamp":1773299810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-0742","authenticated-orcid":false,"given":"Chloe","family":"Sligar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-686X","authenticated-orcid":false,"given":"Ronald","family":"Sluyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8268","authenticated-orcid":false,"given":"Lezanne","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"6","key":"3764_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00839964","volume":"240","author":"AM Chancellor","year":"1993","unstructured":"Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol. 1993;240(6):339\u201346.","journal-title":"J Neurol"},{"issue":"1","key":"3764_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0022-510X(93)90245-T","volume":"118","author":"F Norris","year":"1993","unstructured":"Norris F, Shepherd R, Denys E, U K, Mukai E, Elias L, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993;118(1):48\u201355.","journal-title":"J Neurol Sci"},{"issue":"1","key":"3764_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","volume":"79","author":"G Logroscino","year":"2008","unstructured":"Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79(1):6\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"3764_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771\u20136.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"3764_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s13023-025-04084-6","volume":"20","author":"Y-Q Chen","year":"2025","unstructured":"Chen Y-Q, Yu T, Song Z-Q, Lu Q-C, Jones M, Nisar M, et al. The global burden of motor neuron disease: A systematic and additional analysis of global burden disease study 2021. Orphanet J Rare Dis. 2025;20(1):568.","journal-title":"Orphanet J Rare Dis"},{"issue":"5\u20136","key":"3764_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/21678421.2021.2023190","volume":"23","author":"P Mehta","year":"2022","unstructured":"Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, et al. Incidence of amyotrophic lateral sclerosis in the United States, 2014\u20132016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23(5\u20136):378\u201382.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"3764_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2001-15268","volume":"21","author":"GD Borasio","year":"2001","unstructured":"Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol. 2001;21(2):155\u201366.","journal-title":"Semin Neurol"},{"issue":"2","key":"3764_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162\u201372.","journal-title":"N Engl J Med"},{"key":"3764_CR9","doi-asserted-by":"crossref","unstructured":"Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagnostics (Basel). 2021;11(4):624.","DOI":"10.3390\/diagnostics11040624"},{"issue":"11","key":"3764_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","volume":"6","author":"J Phukan","year":"2007","unstructured":"Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994\u20131003.","journal-title":"Lancet Neurol"},{"key":"3764_CR11","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.","journal-title":"Front Neurosci"},{"issue":"4","key":"3764_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ncl.2015.07.001","volume":"33","author":"K Boylan","year":"2015","unstructured":"Boylan K. Familial amyotrophic lateral sclerosis. Neurol Clin. 2015;33(4):807\u201330.","journal-title":"Neurol Clin"},{"key":"3764_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","volume":"9","author":"D Petrov","year":"2017","unstructured":"Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci. 2017;9:68.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"3764_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","volume":"18","author":"H Sawada","year":"2017","unstructured":"Sawada H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin Pharmacother. 2017;18(7):735\u20138.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3764_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/exnr.1999.7190","volume":"160","author":"II Kruman","year":"1999","unstructured":"Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked Cu\/Zn\u2013SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol. 1999;160(1):28\u201339.","journal-title":"Exp Neurol"},{"issue":"2","key":"3764_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00005072-199602000-00010","volume":"55","author":"C Ikonomidou","year":"1996","unstructured":"Ikonomidou C, Qin YQ, Labruyere J, Olney JW. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1996;55(2):211\u201324.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3764_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ana.410440419","volume":"44","author":"RG Smith","year":"1998","unstructured":"Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1998;44(4):696\u20139.","journal-title":"Ann Neurol"},{"issue":"5","key":"3764_CR18","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","volume":"69","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69(5):2064\u201374.","journal-title":"J Neurochem"},{"issue":"6","key":"3764_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-007-0299-1","volume":"114","author":"S Sasaki","year":"2007","unstructured":"Sasaki S, Horie Y, Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114(6):633\u20139.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3764_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","volume":"33","author":"T Wang","year":"2021","unstructured":"Wang T, Liu H, Itoh K, Oh S, Zhao L, Murata D, et al. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021;33(3):531\u2013e469.","journal-title":"Cell Metab"},{"issue":"3","key":"3764_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013;14(3):161\u201376.","journal-title":"Nat Rev Neurosci"},{"key":"3764_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","volume":"105","author":"KJ De Vos","year":"2017","unstructured":"De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: ppportunities for translational research? Neurobiol Dis. 2017;105:283\u201399.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3764_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-025-00851-y","volume":"20","author":"J Rummens","year":"2025","unstructured":"Rummens J, Da Cruz S. RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights. Mol Neurodegener. 2025;20(1):64.","journal-title":"Mol Neurodegener"},{"key":"3764_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fnmol.2019.00262","volume":"12","author":"L McAlary","year":"2019","unstructured":"McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"3764_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","volume":"10","author":"T Philips","year":"2011","unstructured":"Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10(3):253\u201363.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3764_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"KG Hooten","year":"2015","unstructured":"Hooten KG, Beers DR, Zhao W, Appel SH. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12(2):364\u201375.","journal-title":"Neurotherapeutics"},{"key":"3764_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2014.05.015","volume":"262 Pt B","author":"T Philips","year":"2014","unstructured":"Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp Neurol. 2014;262(Pt B):111\u201320.","journal-title":"Exp Neurol"},{"issue":"4","key":"3764_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.nurt.2010.05.012","volume":"7","author":"MR Vargas","year":"2010","unstructured":"Vargas MR, Johnson JA. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics. 2010;7(4):471\u201381.","journal-title":"Neurotherapeutics"},{"issue":"22","key":"3764_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","volume":"326","author":"JD Rothstein","year":"1992","unstructured":"Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;326(22):1464\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"3764_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615\u201322.","journal-title":"Nat Neurosci"},{"key":"3764_CR31","doi-asserted-by":"publisher","first-page":"803701","DOI":"10.1155\/2012\/803701","volume":"2012","author":"CA Lewis","year":"2012","unstructured":"Lewis CA, Manning J, Rossi F, Krieger C. The neuroinflammatory response in ALS: the roles of microglia and T cells. Neurol Res Int. 2012;2012:803701.","journal-title":"Neurol Res Int"},{"key":"3764_CR32","doi-asserted-by":"crossref","unstructured":"Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005.","DOI":"10.3389\/fimmu.2017.01005"},{"issue":"46","key":"3764_CR33","doi-asserted-by":"publisher","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","volume":"110","author":"CS Lobsiger","year":"2013","unstructured":"Lobsiger CS, Boill\u00e9e S, Pozniak C, Khan AM, McAlonis-Downes M, Lewcock JW, et al. C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proc Natl Acad Sci U S A. 2013;110(46):E4385\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3764_CR34","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446\u201354.","journal-title":"JAMA Neurol"},{"issue":"7","key":"3764_CR35","doi-asserted-by":"publisher","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","volume":"12","author":"MP Gustafson","year":"2017","unstructured":"Gustafson MP, Staff NP, Bornschlegl S, Butler GW, Maas ML, Kazamel M, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS ONE. 2017;12(7):e0182002.","journal-title":"PLoS ONE"},{"issue":"40","key":"3764_CR36","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"DR Beers","year":"2008","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A. 2008;105(40):15558\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3764_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"JI Engelhardt","year":"1993","unstructured":"Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol. 1993;50(1):30\u20136.","journal-title":"Arch Neurol"},{"issue":"1","key":"3764_CR38","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani S, Seitz C, Cui C, Lovik A, Pan L, Piehl F, et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun. 2022;13(1):6733.","journal-title":"Nat Commun"},{"issue":"3","key":"3764_CR39","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140(3):691\u2013707.","journal-title":"Am J Pathol"},{"issue":"4","key":"3764_CR40","first-page":"537","volume":"77","author":"O Komine","year":"2015","unstructured":"Komine O, Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya J Med Sci. 2015;77(4):537\u201349.","journal-title":"Nagoya J Med Sci"},{"issue":"9","key":"3764_CR41","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest. 2017;127(9):3250\u20138.","journal-title":"J Clin Invest"},{"issue":"5","key":"3764_CR42","doi-asserted-by":"publisher","first-page":"e96528","DOI":"10.1371\/journal.pone.0096528","volume":"9","author":"A Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez A, Gamez J, Syriani E, Morales M, Salvado M, Rodr\u00edguez MJ, et al. CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis. PLoS ONE. 2014;9(5):e96528.","journal-title":"PLoS ONE"},{"issue":"6229","key":"3764_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436\u201341.","journal-title":"Science"},{"issue":"5955","key":"3764_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/308145a0","volume":"308","author":"Y Yanagi","year":"1984","unstructured":"Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature. 1984;308(5955):145\u20139.","journal-title":"Nature"},{"issue":"8","key":"3764_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nri3702","volume":"14","author":"MA Yui","year":"2014","unstructured":"Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat Rev Immunol. 2014;14(8):529\u201345.","journal-title":"Nat Rev Immunol"},{"key":"3764_CR46","doi-asserted-by":"crossref","unstructured":"Hosokawa H, Rothenberg EV. Cytokines, transcription factors, and the initiation of T-cell development. Cold Spring Harb Perspect Biol. 2018;10(5):a028621.","DOI":"10.1101\/cshperspect.a028621"},{"issue":"46","key":"3764_CR47","doi-asserted-by":"publisher","first-page":"17913","DOI":"10.1073\/pnas.0804610105","volume":"105","author":"IM Chiu","year":"2008","unstructured":"Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. PNAS. 2008;105(46):17913\u20138.","journal-title":"PNAS"},{"issue":"Pt 5","key":"3764_CR48","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/brain\/awr074","volume":"134","author":"DR Beers","year":"2011","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, et al. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134(Pt 5):1293\u2013314.","journal-title":"Brain"},{"issue":"1","key":"3764_CR49","first-page":"232","volume":"182","author":"N Shi","year":"2007","unstructured":"Shi N, Kawano Y, Tateishi T, Kikuchi H, Osoegawa M, Ohyagi Y, et al. Increased IL-13-producing T cells in ALS: Positive correlations with disease severity and progression rate. J Immunol. 2007;182(1):232\u20135.","journal-title":"J Immunol"},{"issue":"1","key":"3764_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","volume":"210","author":"S Mantovani","year":"2009","unstructured":"Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, Melazzini M, et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol. 2009;210(1):73\u20139.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3764_CR51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","volume":"125","author":"M Rentzos","year":"2012","unstructured":"Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, et al. Alterations of T cell subsets in ALS: a systemic immune activation? Acta Neurol Scand. 2012;125(4):260\u20134.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"3764_CR52","doi-asserted-by":"publisher","first-page":"fcab157","DOI":"10.1093\/braincomms\/fcab157","volume":"3","author":"L Rolfes","year":"2021","unstructured":"Rolfes L, Schulte-Mecklenbeck A, Schreiber S, Vielhaber S, Herty M, Marten A, et al. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Commun. 2021;3(3):fcab157.","journal-title":"Brain Commun"},{"issue":"6","key":"3764_CR53","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1073\/pnas.1815961116","volume":"116","author":"E Coque","year":"2019","unstructured":"Coque E, Salsac C, Espinosa-Carrasco G, Varga B, Degauque N, Cadoux M, et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. PNAS. 2019;116(6):2312\u20137.","journal-title":"PNAS"},{"issue":"2","key":"3764_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/bpa.12351","volume":"26","author":"G Nardo","year":"2016","unstructured":"Nardo G, Trolese MC, Tortarolo M, Vallarola A, Freschi M, Pasetto L, et al. New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models. Brain Pathol. 2016;26(2):237\u201347.","journal-title":"Brain Pathol"},{"key":"3764_CR55","doi-asserted-by":"crossref","unstructured":"Yildiz O, Schroth J, Tree T, Turner MR, Shaw PJ, Henson SM et al. Senescent-like blood lymphocytes and disease progression in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023;10(1):e200046.","DOI":"10.1212\/NXI.0000000000200042"},{"issue":"1","key":"3764_CR56","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1038\/s41467-023-40734-8","volume":"14","author":"J Mandrioli","year":"2023","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E, De Biasi S, Banchelli F, Martinelli I, et al. Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis. Nat Commun. 2023;14(1):4970.","journal-title":"Nat Commun"},{"issue":"13","key":"3764_CR57","doi-asserted-by":"publisher","first-page":"e23796","DOI":"10.1096\/fj.202302659R","volume":"38","author":"RF S\u00eerbulescu","year":"2024","unstructured":"S\u00eerbulescu RF, Nicholson K, Kawai K, Hilton OM, Sobell D, Jin G, et al. Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis. FASEB J. 2024;38(13):e23796.","journal-title":"FASEB J"},{"issue":"3","key":"3764_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2010.22","volume":"7","author":"S Leung","year":"2010","unstructured":"Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol. 2010;7(3):182\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"3764_CR59","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557\u201369.","journal-title":"Blood"},{"issue":"5107","key":"3764_CR60","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.8097338","volume":"260","author":"CS Hsieh","year":"1993","unstructured":"Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O\u2019Garra A, Murphy KM. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993;260(5107):547\u20139.","journal-title":"Science"},{"key":"3764_CR61","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.18.1.451","volume":"18","author":"KM Murphy","year":"2000","unstructured":"Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, et al. Signaling and transcription in T helper development. Annu Rev Immunol. 2000;18:451\u201394.","journal-title":"Annu Rev Immunol"},{"issue":"5969","key":"3764_CR62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1178334","volume":"327","author":"JJ O\u2019Shea","year":"2010","unstructured":"O\u2019Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 2010;327(5969):1098\u2013102.","journal-title":"Science"},{"issue":"1","key":"3764_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ni.1969","volume":"12","author":"V Lazarevic","year":"2011","unstructured":"Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, et al. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR\u03b3t. Nat Immunol. 2011;12(1):96\u2013104.","journal-title":"Nat Immunol"},{"issue":"8","key":"3764_CR64","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/eji.200323787","volume":"33","author":"G Xanthou","year":"2003","unstructured":"Xanthou G, Duchesnes CE, Williams TJ, Pease JE. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol. 2003;33(8):2241\u201350.","journal-title":"Eur J Immunol"},{"issue":"7","key":"3764_CR65","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136(7):2348\u201357.","journal-title":"J Immunol"},{"key":"3764_CR66","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-012459460-9\/50015-9","volume-title":"Immunoregulation in Health and Disease","author":"L Toma\u0161evi\u0107","year":"1997","unstructured":"Toma\u0161evi\u0107 L, Maggi E, Romagnani S. Pathophysiology of Th1 and Th2 Responses in Humans. In: Luki\u0107 ML, \u010coli\u0107 M, Mostarica-Stojkovi\u0107 M, \u010cuperlovi\u0107 K, editors. Immunoregulation in Health and Disease. San Diego: Academic; 1997. pp. 149\u201366."},{"issue":"6","key":"3764_CR67","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24(6):677\u201388.","journal-title":"Immunity"},{"issue":"2","key":"3764_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179\u201389.","journal-title":"Immunity"},{"issue":"7090","key":"3764_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"key":"3764_CR70","doi-asserted-by":"publisher","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","volume":"80","author":"B Wu","year":"2020","unstructured":"Wu B, Wan Y. Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol. 2020;80:106187.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"3764_CR71","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","volume":"179","author":"TJ Harris","year":"2007","unstructured":"Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, et al. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179(7):4313\u20137.","journal-title":"J Immunol"},{"issue":"6","key":"3764_CR72","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1074-7613(00)80645-7","volume":"9","author":"Y-W He","year":"1998","unstructured":"He Y-W, Deftos ML, Ojala EW, Bevan MJ. ROR\u03b3t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity. 1998;9(6):797\u2013806.","journal-title":"Immunity"},{"issue":"12","key":"3764_CR73","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","volume":"181","author":"T Yamazaki","year":"2008","unstructured":"Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol. 2008;181(12):8391\u2013401.","journal-title":"J Immunol"},{"key":"3764_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12974-015-0351-3","volume":"12","author":"IL McWilliams","year":"2015","unstructured":"McWilliams IL, Rajbhandari R, Nozell S, Benveniste E, Harrington LE. STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE. J Neuroinflammation. 2015;12:128.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3764_CR75","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri L, Gy\u00fclv\u00e9szi G, Tosevski V, Hesske L, Fontana A, Magnenat L, et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol. 2011;12(6):560\u20137.","journal-title":"Nat Immunol"},{"key":"3764_CR76","doi-asserted-by":"publisher","first-page":"968549","DOI":"10.1155\/2013\/968549","volume":"2013","author":"N Qu","year":"2013","unstructured":"Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:968549.","journal-title":"Clin Dev Immunol"},{"key":"3764_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-7-76","volume":"7","author":"M Fiala","year":"2010","unstructured":"Fiala M, Chattopadhay M, La Cava A, Tse E, Liu G, Lourenco E, et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J Neuroinflammation. 2010;7:76.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3764_CR78","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"CH Lu","year":"2016","unstructured":"Lu CH, Allen K, Oei F, Leoni E, Kuhle J, Tree T, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e244.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3764_CR79","doi-asserted-by":"publisher","first-page":"102604","DOI":"10.1016\/j.coi.2025.102604","volume":"95","author":"F Dei Zotti","year":"2025","unstructured":"Dei Zotti F, Hudson KE. Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia. Curr Opin Immunol. 2025;95:102604.","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"3764_CR80","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/eji.201040539","volume":"40","author":"MH Lexberg","year":"2010","unstructured":"Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, et al. IFN-\u03b3 and IL-12 synergize to convert in vivo generated Th17 into Th1\/Th17 cells. Eur J Immunol. 2010;40(11):3017\u201327.","journal-title":"Eur J Immunol"},{"issue":"3","key":"3764_CR81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.1993","volume":"12","author":"K Hirota","year":"2011","unstructured":"Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol. 2011;12(3):255\u201363.","journal-title":"Nat Immunol"},{"issue":"6","key":"3764_CR82","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/bloodadvances.2016002980","volume":"1","author":"KH Gartlan","year":"2017","unstructured":"Gartlan KH, Varelias A, Koyama M, Robb RJ, Markey KA, Chang K, et al. Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT. Blood Adv. 2017;1(6):341\u201351.","journal-title":"Blood Adv"},{"issue":"4","key":"3764_CR83","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.smim.2014.06.003","volume":"26","author":"JE Allen","year":"2014","unstructured":"Allen JE, Sutherland TE. Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. Semin Immunol. 2014;26(4):329\u201340.","journal-title":"Semin Immunol"},{"issue":"8","key":"3764_CR84","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3476","volume":"13","author":"WC Gause","year":"2013","unstructured":"Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol. 2013;13(8):607\u201314.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3764_CR85","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","volume":"4","author":"MH Kaplan","year":"1996","unstructured":"Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 1996;4(3):313\u20139.","journal-title":"Immunity"},{"issue":"1","key":"3764_CR86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","volume":"11","author":"T Imai","year":"1999","unstructured":"Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11(1):81\u20138.","journal-title":"Int Immunol"},{"issue":"23","key":"3764_CR87","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","volume":"272","author":"T Imai","year":"1997","unstructured":"Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036\u201342.","journal-title":"J Biol Chem"},{"issue":"3","key":"3764_CR88","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","volume":"273","author":"T Imai","year":"1998","unstructured":"Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998;273(3):1764\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"3764_CR89","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1189\/jlb.68.4.568","volume":"68","author":"J Yamamoto","year":"2000","unstructured":"Yamamoto J, Adachi Y, Onoue Y, Adachi YS, Okabe Y, Itazawa T, et al. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4\u2009+\u2009T cells. J Leukoc Biol. 2000;68(4):568\u201374.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"3764_CR90","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.4049\/jimmunol.1101283","volume":"187","author":"B Upadhyaya","year":"2011","unstructured":"Upadhyaya B, Yin Y, Hill BJ, Douek DC, Prussin C. Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells. J Immunol. 2011;187(6):3111\u201320.","journal-title":"J Immunol"},{"issue":"1","key":"3764_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.183.1.195","volume":"183","author":"PS Foster","year":"1996","unstructured":"Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996;183(1):195\u2013201.","journal-title":"J Exp Med"},{"issue":"3","key":"3764_CR92","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.168.3.853","volume":"168","author":"DA Lebman","year":"1988","unstructured":"Lebman DA, Coffman RL. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med. 1988;168(3):853\u201362.","journal-title":"J Exp Med"},{"issue":"4","key":"3764_CR93","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","volume":"182","author":"PD Collins","year":"1995","unstructured":"Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182(4):1169\u201374.","journal-title":"J Exp Med"},{"issue":"1","key":"3764_CR94","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176(1):287\u201392.","journal-title":"J Exp Med"},{"issue":"5","key":"3764_CR95","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1159\/000376579","volume":"7","author":"F Sheikh","year":"2015","unstructured":"Sheikh F, Dickensheets H, Pedras-Vasconcelos J, Ramalingam T, Helming L, Gordon S, et al. The interleukin-13 receptor-\u03b11 chain is essential for induction of the alternative macrophage activation pathway by IL-13 but not IL-4. J Innate Immun. 2015;7(5):494\u2013505.","journal-title":"J Innate Immun"},{"issue":"4","key":"3764_CR96","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2567.1999.00711.x","volume":"96","author":"CS Bonder","year":"1999","unstructured":"Bonder CS, Finlay-Jones JJ, Hart PH. Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain. Immunology. 1999;96(4):529\u201336.","journal-title":"Immunology"},{"issue":"2","key":"3764_CR97","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4049\/jimmunol.144.2.570","volume":"144","author":"D Vercelli","year":"1990","unstructured":"Vercelli D, Jabara HH, Lauener RP, Geha RS. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol. 1990;144(2):570\u20133.","journal-title":"J Immunol"},{"issue":"7","key":"3764_CR98","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1073\/pnas.1416922112","volume":"112","author":"E Guenova","year":"2015","unstructured":"Guenova E, Skabytska Y, Hoetzenecker W, Weindl G, Sauer K, Tham M, et al. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc Natl Acad Sci U S A. 2015;112(7):2163\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3764_CR99","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875\u201386.","journal-title":"J Exp Med"},{"issue":"1","key":"3764_CR100","first-page":"e23154","volume":"2","author":"SA Mahmud","year":"2013","unstructured":"Mahmud SA, Manlove LS, Farrar MA. Interleukin-2 and STAT5 in regulatory T cell development and function. Jakstat. 2013;2(1):e23154.","journal-title":"Jakstat"},{"issue":"7169","key":"3764_CR101","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450(7169):566\u20139.","journal-title":"Nature"},{"issue":"3","key":"3764_CR102","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","volume":"13","author":"M Miyara","year":"2007","unstructured":"Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med. 2007;13(3):108\u201316.","journal-title":"Trends Mol Med"},{"issue":"11","key":"3764_CR103","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ni1264","volume":"6","author":"LM D\u2019Cruz","year":"2005","unstructured":"D\u2019Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol. 2005;6(11):1152\u20139.","journal-title":"Nat Immunol"},{"issue":"7","key":"3764_CR104","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490\u2013500.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3764_CR105","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204(6):1257\u201365.","journal-title":"J Exp Med"},{"issue":"10","key":"3764_CR106","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1111\/j.1600-6143.2009.02777.x","volume":"9","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Yan J, Putheti P, Wu Y, Sun X, Toxavidis V, et al. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am J Transpl. 2009;9(10):2303\u201311.","journal-title":"Am J Transpl"},{"issue":"6","key":"3764_CR107","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/cmi.2016.30","volume":"14","author":"J Gu","year":"2017","unstructured":"Gu J, Ni X, Pan X, Lu H, Lu Y, Zhao J, et al. Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions. Cell Mol Immunol. 2017;14(6):521\u20138.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3764_CR108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20(1):62\u20138.","journal-title":"Nat Med"},{"key":"3764_CR109","doi-asserted-by":"crossref","unstructured":"Gianchecchi E, Fierabracci A. Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in Treg development and their involvement in autoimmunity onset and cancer progression. Front Immunol. 2018;9:2374.","DOI":"10.3389\/fimmu.2018.02374"},{"issue":"9","key":"3764_CR110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","volume":"26","author":"B Engelhardt","year":"2005","unstructured":"Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26(9):485\u201395.","journal-title":"Trends Immunol"},{"key":"3764_CR111","doi-asserted-by":"crossref","unstructured":"Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y. Neuroinflammation: microglia and T cells get ready to tango. Front Immunol. 2018;8:1905.","DOI":"10.3389\/fimmu.2017.01905"},{"issue":"1","key":"3764_CR112","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1742-2094-9-144","volume":"9","author":"N Vardjan","year":"2012","unstructured":"Vardjan N, Gabrijel M, Potokar M, \u0160vajger U, Kreft M, Jeras M, et al. IFN-\u03b3-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J Neuroinflammation. 2012;9(1):144.","journal-title":"J Neuroinflammation"},{"key":"3764_CR113","doi-asserted-by":"publisher","first-page":"578180","DOI":"10.1016\/j.jneuroim.2023.578180","volume":"383","author":"K Biswas","year":"2023","unstructured":"Biswas K. Microglia mediated neuroinflammation in neurodegenerative diseases: a review on the cell signaling pathways involved in microglial activation. J Neuroimmunol. 2023;383:578180.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3764_CR114","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"ICM Hoogland","year":"2015","unstructured":"Hoogland ICM, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;12(1):114.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"3764_CR115","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","volume":"45","author":"O Kann","year":"2022","unstructured":"Kann O, Almouhanna F, Chausse B. Interferon \u03b3: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci. 2022;45(12):913\u201327.","journal-title":"Trends Neurosci"},{"issue":"6","key":"3764_CR116","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ni.2044","volume":"12","author":"MJ McGeachy","year":"2011","unstructured":"McGeachy MJ. GM-CSF: the secret weapon in the TH17 arsenal. Nat Immunol. 2011;12(6):521\u20132.","journal-title":"Nat Immunol"},{"key":"3764_CR117","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.pneurobio.2024.102587","volume":"235","author":"V La Cognata","year":"2024","unstructured":"La Cognata V, Morello G, Guarnaccia M, Cavallaro S. The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology. Prog Neurobiol. 2024;235:102587.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"3764_CR118","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/glia.10193","volume":"41","author":"E Ambrosini","year":"2003","unstructured":"Ambrosini E, Columba-Cabezas S, Serafini B, Muscella A, Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha\/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia. 2003;41(3):290\u2013300.","journal-title":"Glia"},{"issue":"2","key":"3764_CR119","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-022-02445-0","volume":"144","author":"D Hermans","year":"2022","unstructured":"Hermans D, Houben E, Baeten P, Slaets H, Janssens K, Hoeks C, et al. Oncostatin M triggers brain inflammation by compromising blood\u2013brain barrier integrity. Acta Neuropathol. 2022;144(2):259\u201381.","journal-title":"Acta Neuropathol"},{"key":"3764_CR120","doi-asserted-by":"publisher","first-page":"114561","DOI":"10.1016\/j.expneurol.2023.114561","volume":"370","author":"N Yao","year":"2023","unstructured":"Yao N, Li Y, Han J, Wu S, Liu X, Wang Q, et al. Microglia-derived CCL20 deteriorates neurogenesis following intraventricular hemorrhage. Exp Neurol. 2023;370:114561.","journal-title":"Exp Neurol"},{"key":"3764_CR121","doi-asserted-by":"crossref","unstructured":"Evangelista BA, Ragusa JV, Pellegrino K, Wu Y, Quiroga-Barber IY, Cahalan SR et al. ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation. iScience. 2025;28(6):112345.","DOI":"10.1016\/j.isci.2025.112648"},{"issue":"4","key":"3764_CR122","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820410020286","volume":"5","author":"M Graves","year":"2004","unstructured":"Graves M, Fiala M, Dinglasan LA, Liu N, Sayre J, Chiappelli F, et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):213\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"5","key":"3764_CR123","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2990.1990.tb01276.x","volume":"16","author":"D Troost","year":"1990","unstructured":"Troost D, van den Oord JJ, Jong JMBVD. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 1990;16(5):401\u201310.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1\u20132","key":"3764_CR124","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","volume":"159","author":"R Zhang","year":"2005","unstructured":"Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2005;159(1\u20132):215\u201324.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"3764_CR125","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0404.2010.01333.x","volume":"122","author":"M Rentzos","year":"2010","unstructured":"Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, et al. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? Acta Neurol Scand. 2010;122(6):425\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"3764_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","volume":"148","author":"M Saresella","year":"2013","unstructured":"Saresella M, Piancone F, Tortorella P, Marventano I, Gatti A, Caputo D, et al. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin Immunol. 2013;148(1):79\u201388.","journal-title":"Clin Immunol"},{"issue":"1","key":"3764_CR127","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","volume":"10","author":"M Jin","year":"2020","unstructured":"Jin M, G\u00fcnther R, Akg\u00fcn K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):5941.","journal-title":"Sci Rep"},{"issue":"2","key":"3764_CR128","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019;18(2):211\u201320.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3764_CR129","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8(4):888\u201399.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"3764_CR130","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2018.11.021","volume":"507","author":"MT Rahman","year":"2018","unstructured":"Rahman MT, Ghosh C, Hossain M, Linfield D, Rezaee F, Janigro D, et al. IFN-\u03b3, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: relevance for neuro-inflammatory diseases. Biochem Biophys Res Commun. 2018;507(1):274\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3764_CR131","doi-asserted-by":"publisher","first-page":"152706","DOI":"10.1016\/j.imbio.2023.152706","volume":"228","author":"X Gao","year":"2023","unstructured":"Gao X, Bayraktutan U. TNF-\u03b1 evokes blood-brain barrier dysfunction through activation of Rho-kinase and neurokinin 1 receptor. Immunobiology. 2023;228(5):152706.","journal-title":"Immunobiology"},{"issue":"1","key":"3764_CR132","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","volume":"5","author":"JS Henkel","year":"2013","unstructured":"Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, et al. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5(1):64\u201379.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"3764_CR133","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamaneurol.2018.0035","volume":"75","author":"RK Sheean","year":"2018","unstructured":"Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, et al. Association of regulatory T-cell expansion with progression of amyotrophic lateral sclerosis: a study of humans and a transgenic mouse model. JAMA Neurol. 2018;75(6):681\u20139.","journal-title":"JAMA Neurol"},{"key":"3764_CR134","doi-asserted-by":"crossref","unstructured":"Michaelis T, Lindestam Arlehamn CS, Johansson E, Frazier A, Berry JD, Cudkowicz M et al. Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. Nature. 2025;629:392\u20139.","DOI":"10.1038\/s41586-025-09588-6"},{"issue":"10","key":"3764_CR135","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918\u201329.","journal-title":"Eur J Neurol"},{"key":"3764_CR136","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181\u201393.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"3764_CR137","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","volume":"35","author":"ST Ngo","year":"2014","unstructured":"Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347\u201369.","journal-title":"Front Neuroendocrinol"},{"issue":"3\u20134","key":"3764_CR138","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/21678421.2020.1861022","volume":"22","author":"C Cui","year":"2021","unstructured":"Cui C, Longinetti E, Larsson H, Andersson J, Pawitan Y, Piehl F, et al. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3\u20134):211\u20139.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"3764_CR139","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/cells9020482","volume":"9","author":"M Kunkl","year":"2020","unstructured":"Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L. T helper cells: the modulators of inflammation in multiple sclerosis. Cells. 2020;9(2):482.","journal-title":"Cells"},{"key":"3764_CR140","doi-asserted-by":"publisher","first-page":"740947","DOI":"10.1155\/2014\/740947","volume":"2014","author":"S Li","year":"2014","unstructured":"Li S, Jin T, Zhang HL, Yu H, Meng F, Concha Quezada H, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barr\u00e9 syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014;2014:740947.","journal-title":"Mediators Inflamm"},{"key":"3764_CR141","doi-asserted-by":"publisher","first-page":"638470","DOI":"10.1155\/2015\/638470","volume":"2015","author":"Y Li","year":"2015","unstructured":"Li Y, Liu Y, Chu CQ. Th17 cells in type 1 diabetes: role in the pathogenesis and regulation by gut microbiome. Mediators Inflamm. 2015;2015:638470.","journal-title":"Mediators Inflamm"},{"issue":"14","key":"3764_CR142","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","volume":"81","author":"MR Turner","year":"2013","unstructured":"Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222\u20135.","journal-title":"Neurology"},{"issue":"347","key":"3764_CR143","doi-asserted-by":"publisher","first-page":"347ra93","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8(347):347ra93.","journal-title":"Sci Transl Med"},{"issue":"13\u201314","key":"3764_CR144","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1101\/gad.313932.118","volume":"32","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Burberry A, Wang JY, Sandoe J, Ghosh S, Udeshi ND, et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32(13\u201314):929\u201343.","journal-title":"Genes Dev"},{"issue":"1","key":"3764_CR145","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12916-022-02578-9","volume":"20","author":"P Alipour","year":"2022","unstructured":"Alipour P, Senkevich K, Ross JP, Spiegelman D, Manousaki D, Dion PA, et al. Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study. BMC Med. 2022;20(1):382.","journal-title":"BMC Med"},{"issue":"1","key":"3764_CR146","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12974-023-03007-1","volume":"21","author":"S Zaccai","year":"2024","unstructured":"Zaccai S, Nemirovsky A, Lerner L, Alfahel L, Eremenko E, Israelson A, et al. CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2024;21(1):17.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3764_CR147","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1111\/cns.70061","volume":"30","author":"H He","year":"2024","unstructured":"He H, Zhang X, He H, Xu G, Li L, Yang C, et al. Microglial priming by IFN-\u03b3 involves STAT1-mediated activation of the NLRP3 inflammasome. CNS Neurosci Ther. 2024;30(10):e70061.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"3764_CR148","first-page":"4","volume":"30","author":"SH Appel","year":"2011","unstructured":"Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30(1):4\u20138.","journal-title":"Acta Myol"},{"issue":"2","key":"3764_CR149","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2003","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-\u03b3: an overview of signals, mechanisms and functions. J Leuckoc Biol. 2003;75(2):163\u201389.","journal-title":"J Leuckoc Biol"},{"issue":"5168","key":"3764_CR150","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist C-A, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-\u03b3 mediated by the transactivator gene CIITA. Science. 1994;265(5168):106\u20139.","journal-title":"Science"},{"issue":"10","key":"3764_CR151","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.1813562116","volume":"116","author":"TT Ta","year":"2019","unstructured":"Ta TT, Dikmen HO, Schilling S, Chausse B, Lewen A, Hollnagel JO, et al. Priming of microglia with IFN-\u03b3 slows neuronal gamma oscillations in situ. Proc Natl Acad Sci U S A. 2019;116(10):4637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"3764_CR152","doi-asserted-by":"publisher","first-page":"e1787232024","DOI":"10.1523\/JNEUROSCI.1787-23.2024","volume":"44","author":"C Chun","year":"2024","unstructured":"Chun C, Lee JH, Bothwell M, Nghiem P, Smith AST, Mack DL. Human motor neurons elicit pathological hallmarks of ALS and reveal potential biomarkers of the disease in response to prolonged IFN\u03b3 exposure. J Neurosci. 2024;44(16):e1787232024.","journal-title":"J Neurosci"},{"issue":"6","key":"3764_CR153","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1096\/fj.07-099499","volume":"22","author":"T Mizuno","year":"2008","unstructured":"Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, et al. Interferon-\u03b3 directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-\u03b3 receptor and AMPA GluRl receptor. FASEB J. 2008;22(6):1797\u2013806.","journal-title":"FASEB J"},{"issue":"1","key":"3764_CR154","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ejn.14276","volume":"49","author":"S Sengupta","year":"2019","unstructured":"Sengupta S, Le TT, Adam A, Tadi\u0107 V, Stubendorff B, Keiner S, et al. Interferon-\u03b3 receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice. Eur J Neurosci. 2019;49(1):62\u201378.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"3764_CR155","doi-asserted-by":"publisher","first-page":"e13206","DOI":"10.1111\/bpa.13206","volume":"34","author":"AF Assoni","year":"2024","unstructured":"Assoni AF, Guerrero EN, Wardenaar R, Oliveira D, Bakker PL, Alves LM, et al. IFN\u03b3 protects motor neurons from oxidative stress via enhanced global protein synthesis in FUS-associated amyotrophic lateral sclerosis. Brain Pathol. 2024;34(1):e13206.","journal-title":"Brain Pathol"},{"issue":"7","key":"3764_CR156","doi-asserted-by":"publisher","first-page":"e28553","DOI":"10.1016\/j.heliyon.2024.e28553","volume":"10","author":"C-Z Xu","year":"2024","unstructured":"Xu C-Z, Huan X, Luo S-S, Zhong H-H, Zhao C-B, Chen Y, et al. Serum cytokines profile changes in amyotrophic lateral sclerosis. Heliyon. 2024;10(7):e28553.","journal-title":"Heliyon"},{"key":"3764_CR157","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jim.2015.06.009","volume":"425","author":"A Larsson","year":"2015","unstructured":"Larsson A, Carlsson L, Gordh T, Lind AL, Thulin M, Kamali-Moghaddam M. The effects of age and gender on plasma levels of 63 cytokines. J Immunol Methods. 2015;425:58\u201361.","journal-title":"J Immunol Methods"},{"key":"3764_CR158","doi-asserted-by":"publisher","first-page":"819724","DOI":"10.1155\/2011\/819724","volume":"2011","author":"P Pellegrini","year":"2011","unstructured":"Pellegrini P, Contasta I, Del Beato T, Ciccone F, Berghella AM. Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer. Clin Dev Immunol. 2011;2011:819724.","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"3764_CR159","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/08977190412331279881","volume":"22","author":"JA Hamilton","year":"2004","unstructured":"Hamilton JA, Anderson GP. GM-CSF Biology. Growth Factors. 2004;22(4):225\u201331.","journal-title":"Growth Factors"},{"key":"3764_CR160","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2015.00249","volume":"6","author":"M Greter","year":"2015","unstructured":"Greter M, Lelios I, Croxford AL. Microglia versus myeloid cell nomenclature during brain inflammation. Front Immunol. 2015;6:249.","journal-title":"Front Immunol"},{"issue":"20","key":"3764_CR161","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1093\/hmg\/ddp331","volume":"18","author":"M Manczak","year":"2009","unstructured":"Manczak M, Mao P, Nakamura K, Bebbington C, Park B, Reddy PH. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1\u201342 and suppresses microglial activity in a transgenic mouse model of Alzheimer\u2019s disease. Hum Mol Genet. 2009;18(20):3876\u201393.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"3764_CR162","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1212\/NXI.0000000000000117","volume":"2","author":"CS Constantinescu","year":"2015","unstructured":"Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, et al. Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e117.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"3764_CR163","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mcn.2010.09.001","volume":"46","author":"L Tolosa","year":"2011","unstructured":"Tolosa L, Caraballo-Miralles V, Olmos G, Llad\u00f3 J. TNF-\u03b1 potentiates glutamate-induced spinal cord motoneuron death via NF-\u03baB. Mol Cell Neurosci. 2011;46(1):176\u201386.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"3764_CR164","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.expneurol.2012.08.004","volume":"238","author":"HZ Yin","year":"2012","unstructured":"Yin HZ, Hsu C-I, Yu S, Rao SD, Sorkin LS, Weiss JH. TNF-\u03b1 triggers rapid membrane insertion of Ca2+ permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury. Exp Neurol. 2012;238(2):93\u2013102.","journal-title":"Exp Neurol"},{"key":"3764_CR165","doi-asserted-by":"crossref","unstructured":"Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2(5):e89530.","DOI":"10.1172\/jci.insight.89530"},{"issue":"1","key":"3764_CR166","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","volume":"222","author":"T Tateishi","year":"2010","unstructured":"Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, et al. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol. 2010;222(1):76\u201381.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3764_CR167","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12974-024-03327-w","volume":"21","author":"T Itou","year":"2024","unstructured":"Itou T, Fujita K, Okuzono Y, Warude D, Miyakawa S, Mihara Y, et al. Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study. J Neuroinflammation. 2024;21(1):331.","journal-title":"J Neuroinflammation"},{"issue":"732","key":"3764_CR168","doi-asserted-by":"publisher","first-page":"eadg7895","DOI":"10.1126\/scitranslmed.adg7895","volume":"16","author":"F Limone","year":"2024","unstructured":"Limone F, Couto A, Wang J-Y, Zhang Y, McCourt B, Huang C, et al. Myeloid and lymphoid expression of C9orf72 regulates IL-17A signaling in mice. Sci Transl Med. 2024;16(732):eadg7895.","journal-title":"Sci Transl Med"},{"key":"3764_CR169","doi-asserted-by":"crossref","unstructured":"Jin M, Akg\u00fcn K, Ziemssen T, Kipp M, G\u00fcnther R, Hermann A. Interleukin-17 and Th17 lymphocytes directly impair motoneuron survival of wildtype and FUS-ALS mutant human iPSCs. Int J Mol Sci. 2021;22(15):8052.","DOI":"10.3390\/ijms22158042"},{"key":"3764_CR170","doi-asserted-by":"crossref","unstructured":"Marino J, Paster J, Benichou G. Allorecognition by T lymphocytes and allograft rejection. Front Immunol. 2016;7:582.","DOI":"10.3389\/fimmu.2016.00582"},{"issue":"1","key":"3764_CR171","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell. 2018;23(1):123\u2013e316.","journal-title":"Cell Stem Cell"},{"key":"3764_CR172","doi-asserted-by":"publisher","first-page":"e74065","DOI":"10.7554\/eLife.74065","volume":"11","author":"C Cui","year":"2022","unstructured":"Cui C, Ingre C, Yin L, Li X, Andersson J, Seitz C, et al. Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis. eLife. 2022;11:e74065.","journal-title":"eLife"},{"issue":"4","key":"3764_CR173","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1471-4159.2006.04172.x","volume":"99","author":"W Zhao","year":"2006","unstructured":"Zhao W, Xie W, Xiao Q, Beers DR, Appel SH. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J Neurochem. 2006;99(4):1176\u201387.","journal-title":"J Neurochem"},{"issue":"5","key":"3764_CR174","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bbi.2010.12.008","volume":"25","author":"DR Beers","year":"2011","unstructured":"Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun. 2011;25(5):1025\u201335.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"3764_CR175","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41419-018-0288-4","volume":"9","author":"C Rossi","year":"2018","unstructured":"Rossi C, Cusimano M, Zambito M, Finardi A, Capotondo A, Garcia-Manteiga JM, et al. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis. Cell Death Dis. 2018;9(2):250.","journal-title":"Cell Death Dis"},{"issue":"5\u20136","key":"3764_CR176","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21678421.2020.1752246","volume":"21","author":"I Giovannelli","year":"2020","unstructured":"Giovannelli I, P. H, J. SP, and, Kirby J. The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(5\u20136):435\u201344.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"3764_CR177","doi-asserted-by":"publisher","first-page":"e2740","DOI":"10.1371\/journal.pone.0002740","volume":"3","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, et al. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE. 2008;3(7):e2740.","journal-title":"PLoS ONE"},{"key":"3764_CR178","doi-asserted-by":"crossref","unstructured":"Zucchi E, Banchelli F, Simonini C, De Biasi S, Martinelli I, Gianferrari G et al. Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course. Front Immunol. 2025;15:1467819.","DOI":"10.3389\/fimmu.2024.1508974"},{"key":"3764_CR179","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fneur.2018.00008","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Quan N. Microglia and CNS interleukin-1: beyond immunological concepts. Front Neurol. 2018;9:8.","journal-title":"Front Neurol"},{"issue":"7","key":"3764_CR180","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T. IL-6: regulator of Treg\/Th17 balance. Eur J Immunol. 2010;40(7):1830\u20135.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3764_CR181","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mus.28442","volume":"72","author":"BA Harkey","year":"2025","unstructured":"Harkey BA, Distefano S, Pagliaro JA, Heyd L, Chase M, Igne C, et al. Operational development and launch of an adaptive platform trial in amyotrophic lateral sclerosis: processes and learnings from the first four regimens of the HEALEY ALS Platform Trial. Muscle Nerve. 2025;72(2):294\u2013305.","journal-title":"Muscle Nerve"},{"issue":"3","key":"3764_CR182","first-page":"305","volume":"1","author":"MT Mizwicki","year":"2012","unstructured":"Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, et al. Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. Am J Neurodegener Dis. 2012;1(3):305\u201315.","journal-title":"Am J Neurodegener Dis"},{"issue":"10","key":"3764_CR183","doi-asserted-by":"publisher","first-page":"e0139684","DOI":"10.1371\/journal.pone.0139684","volume":"10","author":"A Maier","year":"2015","unstructured":"Maier A, Deigendesch N, M\u00fcller K, Weishaupt JH, Krannich A, R\u00f6hle R, et al. Interleukin-1 antagonist anakinra in amyotrophic lateral sclerosis - A pilot study. PLoS ONE. 2015;10(10):e0139684.","journal-title":"PLoS ONE"},{"issue":"6","key":"3764_CR184","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mus.25733","volume":"56","author":"JD Berry","year":"2017","unstructured":"Berry JD, Paganoni S, Atassi N, Macklin EA, Goyal N, Rivner M, et al. Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability. Muscle Nerve. 2017;56(6):1077\u201384.","journal-title":"Muscle Nerve"},{"issue":"4","key":"3764_CR185","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","volume":"36","author":"JJ O\u2019Shea","year":"2012","unstructured":"O\u2019Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36(4):542\u201350.","journal-title":"Immunity"},{"key":"3764_CR186","doi-asserted-by":"publisher","first-page":"1662197","DOI":"10.3389\/fimmu.2025.1662197","volume":"16","author":"LA Baird","year":"2025","unstructured":"Baird LA, Teener SJ, Webber-Davis IF, Carter AD, Huang F, Jang DG, et al. Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms. Front Immunol. 2025;16:1662197.","journal-title":"Front Immunol"},{"issue":"6","key":"3764_CR187","doi-asserted-by":"publisher","first-page":"e18904","DOI":"10.1097\/MD.0000000000018904","volume":"99","author":"S Vucic","year":"2020","unstructured":"Vucic S, Ryder J, Mekhael L, Rd H, Mathers S, Needham M, et al. Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): study protocol clinical trial (SPIRIT Compliant). Med (Baltim). 2020;99(6):e18904.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3764_CR188","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1038\/s41467-024-49196-y","volume":"15","author":"L Caldi Gomes","year":"2024","unstructured":"Caldi Gomes L, H\u00e4nzelmann S, Hausmann F, Khatri R, Oller S, Parvaz M, et al. Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target. Nat Commun. 2024;15(1):4893.","journal-title":"Nat Commun"},{"issue":"3","key":"3764_CR189","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-011-0850-y","volume":"122","author":"V Ayala","year":"2011","unstructured":"Ayala V, Granado-Serrano AB, Cacabelos D, Naud\u00ed A, Ilieva EV, Boada J, et al. Cell stress induces TDP-43 pathological changes associated with ERK1\/2 dysfunction: implications in ALS. Acta Neuropathol. 2011;122(3):259\u201370.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3764_CR190","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1042\/BST20220271","volume":"50","author":"RM Lucas","year":"2022","unstructured":"Lucas RM, Luo L, Stow JL. ERK1\/2 in immune signalling. Biochem Soc Trans. 2022;50(5):1341\u201352.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"3764_CR191","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/eji.201242889","volume":"43","author":"H Liu","year":"2013","unstructured":"Liu H, Yao S, Dann SM, Qin H, Elson CO, Cong Y. ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis. Eur J Immunol. 2013;43(7):1716\u201326.","journal-title":"Eur J Immunol"},{"issue":"16","key":"3764_CR192","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1182\/bloodadvances.2023009729","volume":"7","author":"H Wobma","year":"2023","unstructured":"Wobma H, Kapadia M, Kim HT, Alvarez-Calderon F, Baumeister SHC, Duncan C, et al. Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. Blood Adv. 2023;7(16):4647\u201357.","journal-title":"Blood Adv"},{"issue":"2","key":"3764_CR193","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann Rheum Dis. 2019;78(2):209\u201317.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3764_CR194","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ajt.2023.01.016","volume":"23","author":"N Murakami","year":"2023","unstructured":"Murakami N, Borges TJ, Win TS, Abarzua P, Tasigiorgos S, Kollar B, et al. Low-dose interleukin-2 promotes immune regulation in face transplantation: a pilot study. Am J Transpl. 2023;23(4):549\u201358.","journal-title":"Am J Transpl"},{"issue":"4","key":"3764_CR195","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","volume":"5","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, et al. Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study. Neurol Neuroimmunol Neuroinflamm. 2018;5(4):e465.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3764_CR196","doi-asserted-by":"crossref","unstructured":"Thonhoff JR, Berry JD, Macklin EA, Beers DR, Mendoza PA, Zhao W et al. Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9(6):e200011.","DOI":"10.1212\/NXI.0000000000200019"},{"issue":"5","key":"3764_CR197","doi-asserted-by":"publisher","first-page":"EVIDoa2400249","DOI":"10.1056\/EVIDoa2400249","volume":"4","author":"NA Shneider","year":"2025","unstructured":"Shneider NA, Nesta AV, Rifai OM, Yasek J, Elyaman W, Aziz-Zaman S, et al. Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS. NEJM Evid. 2025;4(5):EVIDoa2400249.","journal-title":"NEJM Evid"},{"key":"3764_CR198","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.ebiom.2020.102844","volume":"59","author":"W Camu","year":"2020","unstructured":"Camu W, Mickunas M, Veyrune J-L, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): a phase 2a randomised, double-blind, placebo-controlled trial. eBioMedicine. 2020;59:102844.","journal-title":"eBioMedicine"},{"issue":"1","key":"3764_CR199","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.15147","volume":"1536","author":"H Alarcan","year":"2024","unstructured":"Alarcan H, Bruno C, Emond P, Raoul C, Vourc\u2019h P, Corcia P, et al. Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis. Ann N Y Acad Sci. 2024;1536(1):82\u201391.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3764_CR200","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","volume":"18","author":"Y Chen","year":"2010","unstructured":"Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, et al. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res. 2010;18(2):132\u201342.","journal-title":"Neurotox Res"},{"key":"3764_CR201","doi-asserted-by":"crossref","unstructured":"Cross AR, Lion J, Poussin K, Glotz D, Mooney N. Inflammation determines the capacity of allogenic endothelial cells to regulate human Treg expansion. Front Immunol. 2021;21:666561.","DOI":"10.3389\/fimmu.2021.666531"},{"key":"3764_CR202","doi-asserted-by":"crossref","unstructured":"Wosen JE, Mukhopadhyay D, Macaubas C, Mellins ED. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Front Immunol. 2018;9:2144.","DOI":"10.3389\/fimmu.2018.02144"},{"key":"3764_CR203","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbi.2023.01.013","volume":"109","author":"I Jeric\u00f3","year":"2023","unstructured":"Jeric\u00f3 I, Vicu\u00f1a-Urriza J, Blanco-Luquin I, Macias M, Martinez-Merino L, Rold\u00e1n M, et al. Profiling TREM2 expression in amyotrophic lateral sclerosis. Brain Behav Immun. 2023;109:117\u201326.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"3764_CR204","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1111\/bpa.70019","volume":"35","author":"BA Ashford","year":"2025","unstructured":"Ashford BA, Simpson JE, Dawson C, Boche D, Cooper-Knock J, Heath PR, et al. Human amyotrophic lateral sclerosis\/motor neuron disease: The disease-associated microglial pathway is upregulated while APOE genotype governs risk and survival. Brain Pathol. 2025;35(6):e70019.","journal-title":"Brain Pathol"},{"key":"3764_CR205","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.critrevonc.2025.104824","volume":"214","author":"S Wang","year":"2025","unstructured":"Wang S, Li X, Ning H, Wu Y. Dual-target CAR-T cell therapy: A new strategy to improve the therapeutic effect of hematological malignancies. Crit Rev Oncol\/Hematol. 2025;214:104824.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3764_CR206","doi-asserted-by":"crossref","unstructured":"Blat D, Zigmond E, Alteber Z, Waks T, Eshhar Z. Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol Ther. 2014;22:1010\u20137.","DOI":"10.1038\/mt.2014.41"},{"issue":"8","key":"3764_CR207","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1016\/j.ajt.2025.07.589","volume":"25","author":"KH Schreeb","year":"2025","unstructured":"Schreeb KH, Atkinson GF, Chapman C, Cao LC, Lu Y, Meyer KE, et al. STEADFAST study update: a phase 1\/2 clinical trial of regulatory T cells expressing a chimeric antigen receptor directed towards HLA-A2 in renal transplantation. Am J Transpl. 2025;25(8):S265.","journal-title":"Am J Transpl"},{"issue":"625","key":"3764_CR208","doi-asserted-by":"publisher","first-page":"eabg6986","DOI":"10.1126\/scitranslmed.abg6986","volume":"13","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Hresko ME, Picton LK, Su L, Hollander MJ, Nunez-Cruz S, et al. A human orthogonal IL-2 and IL-2R\u03b2 system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13(625):eabg6986.","journal-title":"Sci Transl Med"},{"key":"3764_CR209","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-0716-1311-5_19","volume-title":"T-Helper Cells: Methods and Protocols","author":"VCW Fung","year":"2021","unstructured":"Fung VCW, Rosado-S\u00e1nchez I, Levings MK. Transduction of human T cell subsets with lentivirus. In: Annunziato F, Maggi L, Mazzoni A, editors. T-Helper Cells: Methods and Protocols. New York, NY: Springer US; 2021. pp. 227\u201354."},{"key":"3764_CR210","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2025.05.019","volume":"184","author":"O Shimon","year":"2025","unstructured":"Shimon O, Dean AM, Cohen S, Moser AL, Dacso CC, Gilad Y, et al. CRISPR-Cas9 engineering of human T regulatory cells \u2013 Design and optimization of a manufacturing process. Mol Immunol. 2025;184:13\u201321.","journal-title":"Mol Immunol"},{"issue":"6","key":"3764_CR211","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ni.1731","volume":"10","author":"MA Koch","year":"2009","unstructured":"Koch MA, Tucker-Heard Gs, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 2009;10(6):595\u2013602.","journal-title":"Nat Immunol"},{"issue":"6","key":"3764_CR212","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/eji.200839123","volume":"39","author":"R Villares","year":"2009","unstructured":"Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Mart\u00ednez-A C, et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur J Immunol. 2009;39(6):1671\u201381.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3764_CR213","doi-asserted-by":"publisher","first-page":"e88318","DOI":"10.1371\/journal.pone.0088318","volume":"9","author":"L Schreiber","year":"2014","unstructured":"Schreiber L, Pietzsch B, Floess S, Farah C, J\u00e4nsch L, Schmitz I, et al. The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-\u03baB signaling. PLoS ONE. 2014;9(2):e88318.","journal-title":"PLoS ONE"},{"issue":"7","key":"3764_CR214","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/bloodadvances.2019000965","volume":"4","author":"A Seng","year":"2020","unstructured":"Seng A, Krausz KL, Pei D, Koestler DC, Fischer RT, Yankee TM, et al. Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells. Blood Adv. 2020;4(7):1325\u201339.","journal-title":"Blood Adv"},{"issue":"6","key":"3764_CR215","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","volume":"23","author":"L Yshii","year":"2022","unstructured":"Yshii L, Pasciuto E, Bielefeld P, Mascali L, Lemaitre P, Marino M, et al. Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation. Nat Immunol. 2022;23(6):878\u201391.","journal-title":"Nat Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03764-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03764-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:03:59Z","timestamp":1776679439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03764-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":215,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3764"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03764-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}